{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:57:34Z","timestamp":1793141854030,"version":"4.5.0"},"reference-count":27,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"unspecified","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015652","name":"Barts Charity","doi-asserted-by":"publisher","award":["MGU0592"],"award-info":[{"award-number":["MGU0592"]}],"id":[{"id":"10.13039\/100015652","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Abbott Medical Ltd","award":["#ISS-EP-2021-000180"],"award-info":[{"award-number":["#ISS-EP-2021-000180"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2024,10,9]]},"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Atrial fibrillation (AF)-induced cardiomyopathy (AIC) is retrospectively defined after normalisation of left ventricular ejection fraction (LVEF) in sinus rhythm. It is unclear why some patients develop AIC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>Patients with AIC have a subtle cardiomyopathic process that precedes their AF-mediated LVEF reduction. Detailed assessment of cardiac function after successful catheter ablation will reveal this.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the utility of measures to identify cardiomyopathic features that persist after LVEF normalisation in AIC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with rate-controlled persistent AF and LVEF&lt;50% undergoing catheter ablation (CA) were prospectively evaluated using echocardiography, cardio-pulmonary exercise testing and serum N-terminal pro b-type natriuretic peptide (NT-proBNP) at baseline and 6\u2009months after CA. Participants with AIC, (LVEF recovery (\u226550%) and no other cause for cardiac dysfunction) were evaluated using left ventricular (LV) longitudinal strain and left atrial (LA) reservoir strain (LARS). Changes in peak oxygen consumption and the minute ventilation\/carbon dioxide production slope were measured as markers of functional capacity and ventilatory inefficiency. A control group of patients with persistent AF with preserved LVEF were also enrolled.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>34\/41 (82.9%) participants recovered LVEF in sinus rhythm; defined as AIC. NT-proBNP levels were elevated in 18 (52.9%), and 16 reported ongoing heart failure (HF) symptoms. 10 (29.4%) had no improvement in functional capacity, and seven (20.6%) showed persistent ventilatory inefficiency. 20 (58.8%) had impaired global LV longitudinal strain with a relative apical sparing pattern. Nine (26.5%) had impaired LARS. There was an overlap of these abnormalities. 32 (94.1%) demonstrated at least one, 17 (50.0%) having no cardiovascular risk factors. Patients with preserved LVEF during persistent AF had similar demographics but a lower burden of short R-R intervals (&lt;660\u2009ms) on Holter monitoring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Abnormal structural, metabolic and HF biomarkers are seen in patients with AIC in sinus rhythm. These features may represent a precedent subtle cardiomyopathic process predisposing them to left ventricular systolic dysfunction in AF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04987723\">NCT04987723<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/openhrt-2024-002955","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T04:16:34Z","timestamp":1732767394000},"page":"e002955","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Characterisation of patients who develop atrial fibrillation-induced cardiomyopathy"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct04987723","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1257-5576","authenticated-orcid":false,"given":"Nikhil","family":"Ahluwalia","sequence":"first","affiliation":[{"name":"St Bartholomew's Hospital, London, UK"},{"name":"William Harvey Research Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohreh","family":"Honarbakhsh","sequence":"additional","affiliation":[{"name":"St Bartholomew's Hospital, London, UK"},{"name":"William Harvey Research Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakam","family":"Abbass","sequence":"additional","affiliation":[{"name":"St Bartholomew's Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Joshi","sequence":"additional","affiliation":[{"name":"St Bartholomew's Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony W C","family":"Chow","sequence":"additional","affiliation":[{"name":"St Bartholomew's Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehul","family":"Dhinoja","sequence":"additional","affiliation":[{"name":"St Bartholomew's Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen Erhard","family":"Petersen","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross J","family":"Hunter","sequence":"additional","affiliation":[{"name":"St Bartholomew's Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Lloyd","sequence":"additional","affiliation":[{"name":"St Bartholomew's Hospital, London, UK"},{"name":"William Harvey Research Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J","family":"Schilling","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"2025081709425682000_11.2.e002955.1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000072767.89944.6E"},{"key":"2025081709425682000_11.2.e002955.2","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.jacc.2024.03.416","article-title":"Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review","volume":"83","author":"Shoureshi","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2025081709425682000_11.2.e002955.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.006855"},{"key":"2025081709425682000_11.2.e002955.4","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1038\/s41598-021-84256-z","article-title":"Reduction of mortality by catheter ablation in real-world atrial fibrillation patients with heart failure","volume":"11","author":"Yang","year":"2021","journal-title":"Sci Rep"},{"key":"2025081709425682000_11.2.e002955.5","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/ejhf.3031","article-title":"Heart failure patients with improved ejection fraction: Insights from the mecki score database","volume":"25","author":"Agostoni","year":"2023","journal-title":"European J of Heart Fail"},{"key":"2025081709425682000_11.2.e002955.6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamacardio.2019.2952","article-title":"Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis","volume":"4","author":"Oikonomou","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2025081709425682000_11.2.e002955.7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/ehjci\/jeaa415","article-title":"Determinants of left atrial reservoir and pump strain and use of atrial strain for evaluation of left ventricular filling pressure","volume":"23","author":"Inoue","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025081709425682000_11.2.e002955.8","unstructured":"Gelder ICV , Rienstra M , Bunting KV , et al . ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Hear J 2024."},{"key":"2025081709425682000_11.2.e002955.9","doi-asserted-by":"publisher","DOI":"10.1530\/ERP-20-0026"},{"key":"2025081709425682000_11.2.e002955.10","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jev014"},{"key":"2025081709425682000_11.2.e002955.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2016.01.011"},{"key":"2025081709425682000_11.2.e002955.12","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31826fb946"},{"key":"2025081709425682000_11.2.e002955.13","first-page":"579","article-title":"Modest Increase in Peak VO 2 Is Related to Better Clinical Outcomes in Chronic Heart Failure Patients","volume":"5","author":"Swank","year":"2012","journal-title":"Circ: Heart Failure"},{"key":"2025081709425682000_11.2.e002955.14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12955-016-0425-7","article-title":"The Minnesota living with heart failure questionnaire: comparison of different factor structures","volume":"14","author":"Bilbao","year":"2016","journal-title":"Health Qual Life Outcomes"},{"key":"2025081709425682000_11.2.e002955.15","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001193"},{"key":"2025081709425682000_11.2.e002955.16","article-title":"ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)","volume":"20","author":"Hindricks","year":"2020","journal-title":"Eur Heart J"},{"key":"2025081709425682000_11.2.e002955.17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.113.000806"},{"key":"2025081709425682000_11.2.e002955.18","article-title":"A randomised trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in chronic heart failure","volume":"126","author":"Jones","year":"2013","journal-title":"Circulation"},{"key":"2025081709425682000_11.2.e002955.19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/hrt.81.3.229","article-title":"Long axis function in disease","volume":"81","author":"Henein","year":"1999","journal-title":"Heart"},{"key":"2025081709425682000_11.2.e002955.20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.523928"},{"key":"2025081709425682000_11.2.e002955.21","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1111\/jvim.17120","article-title":"Longitudinal analysis of echocardiographic and cardiac biomarker variables in dogs with atrial fibrillation: The optimal rate control in dogs with atrial fibrillation II study","volume":"38","author":"Pedro","year":"2024","journal-title":"J Vet Intern Med"},{"key":"2025081709425682000_11.2.e002955.22","first-page":"999","article-title":"Regression of Diffuse Ventricular Fibrosis Following Restoration of Sinus Rhythm With Catheter Ablation in Patients With Atrial Fibrillation and Systolic Dysfunction","volume":"4","author":"Prabhu","year":"2018","journal-title":"JACC: Clinical Electrophysiology"},{"key":"2025081709425682000_11.2.e002955.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707855"},{"key":"2025081709425682000_11.2.e002955.24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.019406"},{"key":"2025081709425682000_11.2.e002955.25","first-page":"27","article-title":"Prognostic Value of Global Longitudinal Strain in Patients With Heart Failure With Improved Ejection Fraction","volume":"10","author":"Janwanishstaporn","year":"2022","journal-title":"JACC: Heart Failure"},{"key":"2025081709425682000_11.2.e002955.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32484-X"},{"key":"2025081709425682000_11.2.e002955.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2021.01.022"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2024-002955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T16:43:05Z","timestamp":1755448985000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2024-002955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,11,27]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1136\/openhrt-2024-002955"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2024-002955","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}